Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2005-1-17
pubmed:abstractText
The kidneys are critical organs in peptide receptor radiation therapy (PRRT). Renal function loss may become apparent many years after PRRT. We analyzed the time course of decline in creatinine clearance (CLR) in patients during a follow-up of at least 18 mo after the start of PRRT with (90)Y-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA),Tyr(3)-octreotide ((90)Y-DOTATOC) or (177)Lu-DOTA(0),Tyr(3)-octreotate ((177)Lu-DOTATATE).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0161-5505
pubmed:author
pubmed:issnType
Print
pubmed:volume
46 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
83S-91S
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15653656-Adult, pubmed-meshheading:15653656-Aged, pubmed-meshheading:15653656-Female, pubmed-meshheading:15653656-Follow-Up Studies, pubmed-meshheading:15653656-Humans, pubmed-meshheading:15653656-Kidney, pubmed-meshheading:15653656-Kidney Function Tests, pubmed-meshheading:15653656-Kidney Neoplasms, pubmed-meshheading:15653656-Longitudinal Studies, pubmed-meshheading:15653656-Male, pubmed-meshheading:15653656-Middle Aged, pubmed-meshheading:15653656-Necrosis, pubmed-meshheading:15653656-Neuroendocrine Tumors, pubmed-meshheading:15653656-Octreotide, pubmed-meshheading:15653656-Organometallic Compounds, pubmed-meshheading:15653656-Radiation Injuries, pubmed-meshheading:15653656-Radiopharmaceuticals, pubmed-meshheading:15653656-Receptors, Peptide, pubmed-meshheading:15653656-Recovery of Function, pubmed-meshheading:15653656-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.
pubmed:affiliation
Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. r.valkema@erasmusmc.nl
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study